Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-30

Clinical Trial Update: The Utility of Levofloxacin-Rifampin in the Therapy of Prosthetic Joint Infection

View source ↗

Summary

This clinical trial evaluated the combination of levofloxacin and rifampin for treating prosthetic joint infections, including those due to Staphylococcus aureu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levofloxacin (Levofloxacin)
  • RIFAMPIN (RIFAMPIN)

Snippet

Sponsor: Mayo Clinic | Conditions: Staphylococcal Infection, Staphylococcus Aureus Prosthetic Joint Infection | Status: COMPLETED